January 30, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Thank you to everyone for attending the NRG2023 Winter Meeting whether you were in-person in Orlando or virtually! Please continue to visit our NRG Meeting Webpages in the weeks following the meeting as we begin to post resources and recordings as they become available.

Save the Date for our Summer meeting, July 20-22 in Philadelphia. 

CLOSURES

BRAIN

NRG-BN010: Temporary Closure Notice dated January 30, 2023 (posted on CTSU). The trial is temporarily closed to accrual for a protocol-specified analysis of safety and tolerability. 

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Actively Recruiting MALE Patients only Read More

2. GYNECOLOGIC

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

GOG-0210: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY012 and NRG-GY023 – BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation. 

NRG-GY028: The Biospecimen Collection and Submission Manual and the Assessment Date Calculator can be found on the NRG Oncology website study page (Documents and Materials tab) during the Phase I portion of the study.

 3. HEAD & NECK

NRG-HN008 Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

4. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, February 8, 2023.

DRUG SAFETY UPDATES

Drug Safety updates have been issued for the following studies:

Request for PILOT Project Applications

Date Issued: December 1, 2022

Submission Due Date: February 17, 2023

NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Health Disparities Research (HDR) priorities. PILOT projects should generate preliminary data and address feasibility issues to inform the development of a future NCORP concept. The current focus of HDC is to move past simply documenting outcome differences to the development and testing of interventions to remedy them. Applications for this award should address committee priorities including:

• Focus 1. Development of interventional studies to decrease health disparities among disparity populations, including racial and ethnic minorities, residents in rural geographic areas, and individuals from other medically underserved groups.
• Focus 2. Testing interventional studies for optimal care of at-risk elderly.
• Focus 3. Identify optimal access to cancer screening, treatment, symptom management and surveillance among diverse disparity populations.

Please see full details located on the NRG Health Disparities Committee webpage.

McKesson Clinical Research Services Operations: Potential Winter Storm

Please review patient schedules and place orders as soon as possible today Monday, January 30, 2023 that are needed for patient treatment this week through Thursday, February 2, 2023. Read full memo here

PUBLICATIONS REMINDERS

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Sherman EJ, Harris J, Bible KC, Xia P, Ghossein RA, Chung CH, Riaz N, Gunn GB, Foote RL, Yom SS, Wong SJ, Koyfman SA, Dzeda MF, Clump DA, Khan SA, Shah MH, Redmond K, Torres-Saavedra PA, Le QT, Lee NY. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial. Lancet Oncol. 2023 Jan 18:S1470-2045(22)00763-X. doi: 10.1016/S1470-2045(22)00763-X. Epub ahead of print. PMID: 36681089. Read more

PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

UPCOMING MEETINGS

American Society of Clinical Oncology (ASCO) GU; Feb 16-18, 2023; San Francisco, CA

ESMO Gynaecological Cancers Annual Congress 2023; Feb 23-24, 2023; Barcelona, Spain

Society of Gynecologic Oncology (SGO); Mar 25-28, 2023; Tampa, FL

Society of Surgical Oncology (SSO) Feb 18-20, 2023; San Diego, CA Advanced Cancer Therapies (ACT)

Society of Surgical Oncology (SSO); March 22-25, 2023; Boston, MA

St. Gallen Breast Cancer Conference (SG-BCC); Mar 15-18, 2023; Vienna, Austria

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association of Physicists in Medicine (AAPM); July 23-27, 2023; Houston, TX; due to publications committee Feb 14, 2023; meeting submission deadline Feb 28, 2023 800 pm ET

American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL; due to publications committee Jan 24, 2023; meeting submission deadline Feb 14, 2023 1159 pm EST; LBA Mar 16, 2023 Noon (EST)

American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; due to publications committee Feb 9, 2023; meeting submission deadline Feb 13, 2023 1159 PT

ESMO Breast Cancer Annual Congress; May 11-13, 2023; Berlin, Germany; due to publications committee Feb 7, 2023; meeting submission deadline Feb 21, 2023 TiP, LBA placeholder 9 pm CET; LBA Apr 12, 2023 9pm CntEurSummrTime

ESMO World Congress on Gastrointestinal Cancer; Jun 28-Jul 21, 2023; Barcelona, Spain; due to publications committee Feb 27, 2023; meeting submission deadline Mar 13, 2023; LBA Jun 15, 2023